APO Research, Inc.

APO RESEARCH · REPORT

Epigenome Analysis Services

Selected research

Industry Growth & Trends

Global Epigenome Analysis Services Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Epigenome Analysis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Epigenome Analysis Services market include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Epigenome Analysis Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Epigenome Analysis Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epigenome Analysis Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epigenome Analysis Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Epigenome Analysis Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Epigenome Analysis Services Market by Company

Cellcentric

Syndax

Illumina

Merck

QIAGEN

F. Hoffmann-La Roche

Eisai

Abcam

Diagenode

Active Motif

Zymo Research Corporation

Thermo Fisher Scientific

Enzo Life Sciences

EpiGentek Group

New England Biolabs

Epizyme

Domainex

Agilent Technologies

AsisChem

Epigenome Analysis Services Segment by Type

DNA Methylation Analysis

Analysis of DNA Interactions

Chromatin Accessibility

Conformation Assays

Epigenome Analysis Services Segment by Application

Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Epigenome Analysis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenome Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenome Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenome Analysis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Epigenome Analysis Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Epigenome Analysis Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Epigenome Analysis Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Epigenome Analysis Services Market Share by Region (2021-2026) Table 4. Global Epigenome Analysis Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Epigenome Analysis Services Market Share by Region (2027-2032) Table 6. Global Epigenome Analysis Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Epigenome Analysis Services Market Size Share by Type (2021-2026) Table 9. Global Epigenome Analysis Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Epigenome Analysis Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Epigenome Analysis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Epigenome Analysis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Epigenome Analysis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Epigenome Analysis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Epigenome Analysis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Epigenome Analysis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Epigenome Analysis Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Epigenome Analysis Services Market Size Share by Application (2021-2026) Table 24. Global Epigenome Analysis Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Epigenome Analysis Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Epigenome Analysis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Epigenome Analysis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Epigenome Analysis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Epigenome Analysis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Epigenome Analysis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Epigenome Analysis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Epigenome Analysis Services Industry Trends Table 37. Epigenome Analysis Services Industry Drivers Table 38. Epigenome Analysis Services Industry Opportunities and Challenges Table 39. Epigenome Analysis Services Industry Restraints Table 40. Global Epigenome Analysis Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Epigenome Analysis Services Revenue Market Share by Company (2021-2026) Table 42. Global Epigenome Analysis Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Epigenome Analysis Services Key Company Headquarters & Area Served Table 44. Global Epigenome Analysis Services Company, Product Type & Application Table 45. Global Epigenome Analysis Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Epigenome Analysis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Cellcentric Company Information Table 49. Cellcentric Business Overview Table 50. Cellcentric Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Cellcentric Epigenome Analysis Services Product Portfolio Table 52. Cellcentric Recent Development Table 53. Syndax Company Information Table 54. Syndax Business Overview Table 55. Syndax Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Syndax Epigenome Analysis Services Product Portfolio Table 57. Syndax Recent Development Table 58. Illumina Company Information Table 59. Illumina Business Overview Table 60. Illumina Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Illumina Epigenome Analysis Services Product Portfolio Table 62. Illumina Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck Epigenome Analysis Services Product Portfolio Table 67. Merck Recent Development Table 68. QIAGEN Company Information Table 69. QIAGEN Business Overview Table 70. QIAGEN Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. QIAGEN Epigenome Analysis Services Product Portfolio Table 72. QIAGEN Recent Development Table 73. F. Hoffmann-La Roche Company Information Table 74. F. Hoffmann-La Roche Business Overview Table 75. F. Hoffmann-La Roche Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio Table 77. F. Hoffmann-La Roche Recent Development Table 78. Eisai Company Information Table 79. Eisai Business Overview Table 80. Eisai Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Eisai Epigenome Analysis Services Product Portfolio Table 82. Eisai Recent Development Table 83. Abcam Company Information Table 84. Abcam Business Overview Table 85. Abcam Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Abcam Epigenome Analysis Services Product Portfolio Table 87. Abcam Recent Development Table 88. Diagenode Company Information Table 89. Diagenode Business Overview Table 90. Diagenode Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Diagenode Epigenome Analysis Services Product Portfolio Table 92. Diagenode Recent Development Table 93. Active Motif Company Information Table 94. Active Motif Business Overview Table 95. Active Motif Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Active Motif Epigenome Analysis Services Product Portfolio Table 97. Active Motif Recent Development Table 98. Zymo Research Corporation Company Information Table 99. Zymo Research Corporation Business Overview Table 100. Zymo Research Corporation Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Zymo Research Corporation Epigenome Analysis Services Product Portfolio Table 102. Zymo Research Corporation Recent Development Table 103. Thermo Fisher Scientific Company Information Table 104. Thermo Fisher Scientific Business Overview Table 105. Thermo Fisher Scientific Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio Table 107. Thermo Fisher Scientific Recent Development Table 108. Enzo Life Sciences Company Information Table 109. Enzo Life Sciences Business Overview Table 110. Enzo Life Sciences Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Enzo Life Sciences Epigenome Analysis Services Product Portfolio Table 112. Enzo Life Sciences Recent Development Table 113. EpiGentek Group Company Information Table 114. EpiGentek Group Business Overview Table 115. EpiGentek Group Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. EpiGentek Group Epigenome Analysis Services Product Portfolio Table 117. EpiGentek Group Recent Development Table 118. New England Biolabs Company Information Table 119. New England Biolabs Business Overview Table 120. New England Biolabs Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. New England Biolabs Epigenome Analysis Services Product Portfolio Table 122. New England Biolabs Recent Development Table 123. Epizyme Company Information Table 124. Epizyme Business Overview Table 125. Epizyme Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Epizyme Epigenome Analysis Services Product Portfolio Table 127. Epizyme Recent Development Table 128. Domainex Company Information Table 129. Domainex Business Overview Table 130. Domainex Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Domainex Epigenome Analysis Services Product Portfolio Table 132. Domainex Recent Development Table 133. Agilent Technologies Company Information Table 134. Agilent Technologies Business Overview Table 135. Agilent Technologies Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Agilent Technologies Epigenome Analysis Services Product Portfolio Table 137. Agilent Technologies Recent Development Table 138. AsisChem Company Information Table 139. AsisChem Business Overview Table 140. AsisChem Epigenome Analysis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. AsisChem Epigenome Analysis Services Product Portfolio Table 142. AsisChem Recent Development Table 143. North America Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Epigenome Analysis Services Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Epigenome Analysis Services Market Share by Country (2021-2026) Table 146. North America Epigenome Analysis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Epigenome Analysis Services Market Share Forecast by Country (2027-2032) Table 148. Europe Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Epigenome Analysis Services Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Epigenome Analysis Services Market Share by Country (2021-2026) Table 151. Europe Epigenome Analysis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Epigenome Analysis Services Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Epigenome Analysis Services Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Epigenome Analysis Services Market Share by Country (2021-2026) Table 156. Asia-Pacific Epigenome Analysis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Epigenome Analysis Services Market Share Forecast by Country (2027-2032) Table 158. Latin America Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Epigenome Analysis Services Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Epigenome Analysis Services Market Share by Country (2021-2026) Table 161. Latin America Epigenome Analysis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Epigenome Analysis Services Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Epigenome Analysis Services Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Epigenome Analysis Services Market Share by Country (2021-2026) Table 166. Middle East & Africa Epigenome Analysis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Epigenome Analysis Services Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Epigenome Analysis Services Product Image Figure 3. Global Epigenome Analysis Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Epigenome Analysis Services Market Share by Region: 2025 VS 2032 Figure 6. Global Epigenome Analysis Services Market Share by Region (2021-2032) Figure 7. North America Epigenome Analysis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Epigenome Analysis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Epigenome Analysis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Epigenome Analysis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Epigenome Analysis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. DNA Methylation Analysis Image Figure 13. Global DNA Methylation Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Analysis of DNA Interactions Image Figure 15. Global Analysis of DNA Interactions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Chromatin Accessibility Image Figure 17. Global Chromatin Accessibility Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Conformation Assays Image Figure 19. Global Conformation Assays Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Epigenome Analysis Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Epigenome Analysis Services Market Share by Type 2025 VS 2032 Figure 22. North America Epigenome Analysis Services Market Size Share by Type (2021-2032) Figure 23. Europe Epigenome Analysis Services Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Epigenome Analysis Services Market Size Share by Type (2021-2032) Figure 25. Latin America Epigenome Analysis Services Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Epigenome Analysis Services Market Size Share by Type (2021-2032) Figure 27. Research Institutes Image Figure 28. Global Research Institutes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Pharmaceutical Companies Image Figure 30. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Biotechnology Companies Image Figure 32. Global Biotechnology Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Epigenome Analysis Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Epigenome Analysis Services Market Share by Application 2025 VS 2032 Figure 37. North America Epigenome Analysis Services Market Size Share by Application (2021-2032) Figure 38. Europe Epigenome Analysis Services Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Epigenome Analysis Services Market Size Share by Application (2021-2032) Figure 40. Latin America Epigenome Analysis Services Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Epigenome Analysis Services Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Epigenome Analysis Services Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Epigenome Analysis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Epigenome Analysis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Epigenome Analysis Services Market Share by Country (2021-2032) Figure 47. Europe Epigenome Analysis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Epigenome Analysis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Epigenome Analysis Services Market Share by Country (2021-2032) Figure 50. Asia-Pacific Epigenome Analysis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Epigenome Analysis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Epigenome Analysis Services Market Share by Country (2021-2032) Figure 53. Latin America Epigenome Analysis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Epigenome Analysis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Epigenome Analysis Services Market Share by Country (2021-2032) Figure 56. Middle East & Africa Epigenome Analysis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Epigenome Analysis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Epigenome Analysis Services Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Analysis
  • Analysis of DNA Interactions
  • Chromatin Accessibility
  • Conformation Assays
Applications
  • Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
Companies covered
  • Cellcentric
  • Syndax
  • Illumina
  • Merck
  • QIAGEN
  • F. Hoffmann-La Roche
  • Eisai
  • Abcam
  • Diagenode
  • Active Motif
  • Zymo Research Corporation
  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • EpiGentek Group
  • New England Biolabs
  • Epizyme
  • Domainex
  • Agilent Technologies
  • AsisChem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Epigenome Analysis Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Epigenome Analysis Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Epigenome Analysis Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Epigenome Analysis Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Epigenome Analysis Services Market Size (2021-2032)
  8. 1.5.1 North America Epigenome Analysis Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Epigenome Analysis Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Epigenome Analysis Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Epigenome Analysis Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Epigenome Analysis Services Market Size Growth Rate (2021-2032)
2 Epigenome Analysis Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 DNA Methylation Analysis
  3. 2.1.2 Analysis of DNA Interactions
  4. 2.1.3 Chromatin Accessibility
  5. 2.1.4 Conformation Assays
  6. 2.2 Global Epigenome Analysis Services Market Size by Type
  7. 2.2.1 Global Epigenome Analysis Services Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Epigenome Analysis Services Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Epigenome Analysis Services Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Epigenome Analysis Services Market Size by Regions
  11. 2.3.1 North America Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
3 Epigenome Analysis Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Research Institutes
  3. 3.1.2 Pharmaceutical Companies
  4. 3.1.3 Biotechnology Companies
  5. 3.1.4 Others
  6. 3.2 Global Epigenome Analysis Services Market Size by Application
  7. 3.2.1 Global Epigenome Analysis Services Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Epigenome Analysis Services Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Epigenome Analysis Services Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Epigenome Analysis Services Market Size by Regions
  11. 3.3.1 North America Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Epigenome Analysis Services Industry Trends
  2. 4.2 Epigenome Analysis Services Industry Drivers
  3. 4.3 Epigenome Analysis Services Industry Opportunities and Challenges
  4. 4.4 Epigenome Analysis Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Epigenome Analysis Services Revenue (2021-2026)
  2. 5.2 Global Epigenome Analysis Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Epigenome Analysis Services Key Company Headquarters & Area Served
  4. 5.4 Global Epigenome Analysis Services Company, Product Type & Application
  5. 5.5 Global Epigenome Analysis Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Epigenome Analysis Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Epigenome Analysis Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Epigenome Analysis Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Cellcentric
  2. 6.1.1 Cellcentric Company Information
  3. 6.1.2 Cellcentric Business Overview
  4. 6.1.3 Cellcentric Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Cellcentric Epigenome Analysis Services Product Portfolio
  6. 6.1.5 Cellcentric Recent Developments
  7. 6.2 Syndax
  8. 6.2.1 Syndax Company Information
  9. 6.2.2 Syndax Business Overview
  10. 6.2.3 Syndax Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Syndax Epigenome Analysis Services Product Portfolio
  12. 6.2.5 Syndax Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Illumina Epigenome Analysis Services Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck Epigenome Analysis Services Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 QIAGEN
  26. 6.5.1 QIAGEN Company Information
  27. 6.5.2 QIAGEN Business Overview
  28. 6.5.3 QIAGEN Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 QIAGEN Epigenome Analysis Services Product Portfolio
  30. 6.5.5 QIAGEN Recent Developments
  31. 6.6 F. Hoffmann-La Roche
  32. 6.6.1 F. Hoffmann-La Roche Company Information
  33. 6.6.2 F. Hoffmann-La Roche Business Overview
  34. 6.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche Recent Developments
  37. 6.7 Eisai
  38. 6.7.1 Eisai Company Information
  39. 6.7.2 Eisai Business Overview
  40. 6.7.3 Eisai Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Eisai Epigenome Analysis Services Product Portfolio
  42. 6.7.5 Eisai Recent Developments
  43. 6.8 Abcam
  44. 6.8.1 Abcam Company Information
  45. 6.8.2 Abcam Business Overview
  46. 6.8.3 Abcam Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Abcam Epigenome Analysis Services Product Portfolio
  48. 6.8.5 Abcam Recent Developments
  49. 6.9 Diagenode
  50. 6.9.1 Diagenode Company Information
  51. 6.9.2 Diagenode Business Overview
  52. 6.9.3 Diagenode Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Diagenode Epigenome Analysis Services Product Portfolio
  54. 6.9.5 Diagenode Recent Developments
  55. 6.10 Active Motif
  56. 6.10.1 Active Motif Company Information
  57. 6.10.2 Active Motif Business Overview
  58. 6.10.3 Active Motif Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Active Motif Epigenome Analysis Services Product Portfolio
  60. 6.10.5 Active Motif Recent Developments
  61. 6.11 Zymo Research Corporation
  62. 6.11.1 Zymo Research Corporation Company Information
  63. 6.11.2 Zymo Research Corporation Business Overview
  64. 6.11.3 Zymo Research Corporation Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Zymo Research Corporation Epigenome Analysis Services Product Portfolio
  66. 6.11.5 Zymo Research Corporation Recent Developments
  67. 6.12 Thermo Fisher Scientific
  68. 6.12.1 Thermo Fisher Scientific Company Information
  69. 6.12.2 Thermo Fisher Scientific Business Overview
  70. 6.12.3 Thermo Fisher Scientific Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Recent Developments
  73. 6.13 Enzo Life Sciences
  74. 6.13.1 Enzo Life Sciences Company Information
  75. 6.13.2 Enzo Life Sciences Business Overview
  76. 6.13.3 Enzo Life Sciences Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Enzo Life Sciences Epigenome Analysis Services Product Portfolio
  78. 6.13.5 Enzo Life Sciences Recent Developments
  79. 6.14 EpiGentek Group
  80. 6.14.1 EpiGentek Group Company Information
  81. 6.14.2 EpiGentek Group Business Overview
  82. 6.14.3 EpiGentek Group Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 EpiGentek Group Epigenome Analysis Services Product Portfolio
  84. 6.14.5 EpiGentek Group Recent Developments
  85. 6.15 New England Biolabs
  86. 6.15.1 New England Biolabs Company Information
  87. 6.15.2 New England Biolabs Business Overview
  88. 6.15.3 New England Biolabs Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 New England Biolabs Epigenome Analysis Services Product Portfolio
  90. 6.15.5 New England Biolabs Recent Developments
  91. 6.16 Epizyme
  92. 6.16.1 Epizyme Company Information
  93. 6.16.2 Epizyme Business Overview
  94. 6.16.3 Epizyme Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Epizyme Epigenome Analysis Services Product Portfolio
  96. 6.16.5 Epizyme Recent Developments
  97. 6.17 Domainex
  98. 6.17.1 Domainex Company Information
  99. 6.17.2 Domainex Business Overview
  100. 6.17.3 Domainex Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Domainex Epigenome Analysis Services Product Portfolio
  102. 6.17.5 Domainex Recent Developments
  103. 6.18 Agilent Technologies
  104. 6.18.1 Agilent Technologies Company Information
  105. 6.18.2 Agilent Technologies Business Overview
  106. 6.18.3 Agilent Technologies Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Agilent Technologies Epigenome Analysis Services Product Portfolio
  108. 6.18.5 Agilent Technologies Recent Developments
  109. 6.19 AsisChem
  110. 6.19.1 AsisChem Company Information
  111. 6.19.2 AsisChem Business Overview
  112. 6.19.3 AsisChem Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 AsisChem Epigenome Analysis Services Product Portfolio
  114. 6.19.5 AsisChem Recent Developments
7 North America
  1. 7.1 North America Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Epigenome Analysis Services Market Size by Country (2021-2026)
  3. 7.3 North America Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Epigenome Analysis Services Market Size by Country (2021-2026)
  3. 8.3 Europe Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Epigenome Analysis Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Epigenome Analysis Services Market Size by Country (2021-2026)
  3. 10.3 South America Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Epigenome Analysis Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.